Stocks · Health care · Pharmaceutical Preparations

GALECTIN THERAPEUTICS INC

GALT Clue Score21
United States Fiscal year ends December CIK 0001133416 Results filed 14 Aug 2026

What the insiders did Net buying

By person

16 insiders · 254 transactions
6.8×

Joel Lewis holds 6.8 times base salary in stock. $4.28M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joel Lewis last reported holding, valued at $5.13, the price Common Stock was last bought or sold at on the open market here, on 14 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Richard E Uihlein
Director
$20.51M (7)
—
+$20.51M
55,074,229
$282.27M
+325.1%
10X Fund, L.P. entity
10% owner
—
$7.20M (42)
−$7.20M
11,385,227
$58.35M
+32.7%
James C Czirr
10% owner
—
$5.11M (16)
−$5.11M
15,907,874
$81.53M
−0.5%
Jack W Callicutt
Chief Financial Officer
$15.36K (2)
$4.00M (29) scheduled
−$3.98M
7,614
$39.02K
+504.3%
Harold H. Shlevin
Director
$7.54K (1)
$3.83M (24) scheduled
−$3.83M
26,123
$133.89K
−64.4%
Khurram Jamil
Chief Medical Officer
—
$1.45M (18) scheduled
−$1.45M
0
$0.00
—
Peter G Traber
President & CEO
—
$1.16M (2) scheduled
−$1.16M
107,333
$550.10K
0.0%
Marc Rubin
Director
$12.97K (1)
$739.77K (5) scheduled
−$726.80K
13,581
$69.61K
−72.0%
Joel Lewis
President and CEO
$79.47K (7)
$759.19K (12) scheduled
−$679.73K
834,592
$4.28M
+3,459%
Gilbert F Amelio
Director
—
$379.20K (4)
−$379.20K
60,614
$310.66K
+8.3%
Kevin D Freeman
Director
$308.33K (31)
—
+$308.33K
192,269
$985.42K
+197.7%
Kary Eldred
Director
$54.22K (13)
—
+$54.22K
70,107
$359.31K
+60.8%
Richard A. Zordani Jr.
Director
$50.36K (8)
—
+$50.36K
44,083
$225.93K
+202.3%
Gilbert S Omenn
Director
$79.51K (1)
$116.59K (2)
−$37.07K
66,769
$342.20K
−1.2%
Theodore Daniel Zucconi
Director
$2.27K (1)
$14.32K (1) scheduled
−$12.05K
1,083
$5.55K
+1,205%
Elissa J. Schwartz
Director
$2.00K (1)
—
+$2.00K
1,000
$5.13K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.